Clinical Trial Update: Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine [Phase 3]

View source ↗

Summary

This clinical trial update indicates that a Phase 3 study of the combined administration of a 15-valent pneumococcal conjugate vaccine and a diphtheria-tetanus-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcus Pneumoniae Infections

Drugs mentioned

• Diphtheria, Tetanus, and Pertussis vaccine (Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP))
• Zhifei 15-valent pneumococcal conjugate vaccine (Pneumococcal conjugate vaccine, 15-valent)

Snippet

Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Conditions: Streptococcus Pneumoniae Infections | Phase 3 | Status: COMPLETED